0000820313 false 0000820313 2020-05-19 2020-05-20 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of

The Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported):  May 20, 2020

 

AMPHENOL CORPORATION

(Exact name of registrant as specified in its charter)

 

 

Delaware   1-10879   22-2785165
(State or other jurisdiction of incorporation)   (Commission File Number)   (IRS Employer Identification No.)

 

 

358 Hall Avenue, Wallingford, Connecticut   06492
(Address of principal executive offices)   (Zip Code)

 

Registrant’s telephone number, including area code: (203) 265-8900

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
Class A Common Stock, $0.001 par value   APH   New York Stock Exchange

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

 

Emerging growth company ¨

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

  

 

 

 

 

Item 5.07 Submission of Matters to a Vote of Security Holders

 

The annual meeting of stockholders of the Company was held on May 20, 2020.  As of March 23, 2020, the record date for the meeting, 295,845,244 shares of the Company’s Class A Common Stock were outstanding.  A quorum of 272,639,141 shares were present or represented at the meeting.

 

The stockholders (i) elected each of the Company’s nominees for director, (ii) ratified the selection of Deloitte & Touche LLP as independent accountants of the Company, (iii) approved the advisory vote on compensation of named executive officers and (iv) voted against a stockholder proposal to make shareholder right to call special meeting more accessible.  Voting of shares for each item, all of which are described in the Company’s Proxy Statement filed with the Securities and Exchange Commission on April 13, 2020, is as follows:

 

1.  ELECTION OF DIRECTORS

 

FOR the nominees:

 

       Votes   ABSTAIN     
Nominee  Votes FOR   AGAINST   Votes   NON-VOTES 
Stanley L. Clark   248,620,945    16,430,644    93,425    7,494,127 
John D. Craig   255,297,196    9,753,024    94,794    7,494,127 
David P. Falck   262,694,585    2,357,269    93,160    7,494,127 
Edward G. Jepsen   261,497,618    3,552,584    94,812    7,494,127 
Robert A. Livingston   261,500,177    3,550,898    93,939    7,494,127 
Martin H. Loeffler   260,271,910    4,789,817    83,287    7,494,127 
R. Adam Norwitt   240,637,100    23,140,413    1,367,501    7,494,127 
Anne Clarke Wolff   257,830,687    7,220,231    94,096    7,494,127 

 

2.  RATIFICATION OF SELECTION OF DELOITTE & TOUCHE LLP AS INDEPENDENT PUBLIC ACCOUNTANTS OF THE COMPANY

 

 

FOR   263,253,094   AGAINST   8,843,631
             
ABSTAIN   542,416   NON-VOTES   0

 

3.  ADVISORY VOTE ON COMPENSATION OF NAMED EXECUTIVE OFFICERS

 

FOR   240,953,272   AGAINST   23,910,788
             
ABSTAIN   280,954   NON-VOTES   7,494,127

 

4.   STOCKHOLDER PROPOSAL TO MAKE SHAREHOLDER RIGHT TO CALL SPECIAL MEETING MORE ACCESSIBLE

 

FOR   112,947,303   AGAINST   152,057,859
             
ABSTAIN   139,852   NON-VOTES   7,494,127

 

Item 9.01. Financial Statements and Exhibits.

 

(d) Exhibits

 

Exhibit No.  Document Description
    
104  Cover Page Interactive Data File – the cover page XBRL tags are embedded within the Inline XBRL document 

 

 

 

 

Signature

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

    AMPHENOL CORPORATION
     
  By: /s/ Lance E. D’Amico
    Lance E. D’Amico
    Senior Vice President, Secretary and General Counsel
     
Date: May 21, 2020